News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
News By Date


Thursday, September 21, 2017

Top Breaking News

News from Around the Web
How Juno (JUNO)'s Spanking New HQ Is Designed To Slay Cancer
Amgen (AMGN)'s Big Influence On New And Old Biotechs In SoCal
The 7 Deadly Sins Of Innovation And Digital Health
The Biotech Devil's Dictionary: Your Guide To The Inanities Of Industry Jargon
Why Women Are Leaving The Life Sciences In Massachusetts, Massachusetts Biotechnology Council Reveals
CRISPR Opens Window Into Early Stages Of Human Embryo Development, Nature Reveals
How Will Artificial Intelligence Impact Alzheimer’s Research?
Wuhan's XW Laboratories Inc. Closes $17.5 Million B Round To Develop CNS Drugs
UK Warns About Alarm Failure for Roche (RHHBY)’s Accu-Check Insight Insulin Pumps
Scientists Develop Counterfeit Booze-Detecting Device, University of Manchester Reveals
Scientists Create World's First 'Molecular Robot' Capable Of Building Molecules, University of Manchester Study
Beyond Bobbleheads: One NFL Team Wants To Offer Fans Free Genetic Testing

Press Releases
200 Jobs Saved After Recipharm, Roche (RHHBY) Ink Manufacturing Pact
Heads Up Startups: There's Space For 6 Biotechs At Pfizer (PFE)'s Kendall Square R&D Campus
Chris Garabedian's Xontogeny Takes On Its First Baby, Landos Biopharma With $10 Million
ISCT Completes Strategic Reorganization With CEO Appointment
Theravance Biopharma (TBPH) Highlights Positive Headline Results From IMPACT Study Of Trelegy Ellipta Announced By GlaxoSmithKline (GSK) And Innoviva Inc. (THRX)
Patara Pharma's Phase II Study Results For Treatment Of Persistent Cough In IPF Patients Published In The Lancet Respiratory Medicine
Akari to Push Lead Drug Into Phase III For PNH In Q1 2018, Stock Surges
GENFIT (ALGFT): Risk Of Confusion Between PPAR Alpha/Delta Phase III Drug Candidate Elafibranor And PPAR A/D/Gamma Phase II Compound Lanifibranor
Arbutus Biopharma (ABUS)’ LNP Licensee Alnylam (ALNY) Announces Positive Phase III Results For LNP-Enabled Patisiran Program
PhaseRx (PZRX) Receives Orphan Drug Designation From FDA For PRX-ASL For The Treatment Of Argininosuccinate Lyase Deficiency
Biocryst (BCRX)’s RAPIVAB (peramivir injection) Receives FDA Approval For A Pediatric Indication
Amphastar (AMPH) Receives FDA Approval For Sodium Bicarbonate Injection
Perrigo (PRGO) Announces FDA Final Approval For Its AB Rated Generic Version Of Exalgo 32mg Extended Release Tablets
AstraZeneca Canada (AZN) Release: First-In-Class BRCA-Positive Ovarian Cancer Medicine Lynparza (Olaparib) Receives Positive Pan-Canadian Oncology Drug Review (pCODR) Recommendation For Provincial Reimbursement
Paratek (PRTK) Release: Omadacycline Receives Qualified Infectious Disease Product Designation From FDA For An Additional Indication In Uncomplicated Urinary Tract Infection
Bavarian Nordic (BAVA.CO) Provides Update On Its Universal RSV Vaccine
GrayBug Initiates Phase 1/2 Trial Of GB-102 For Wet Age-Related Macular Degeneration
FLX Bio Selects Immuno-Oncology Clinical Candidate
Sanofi (SNY) And NIH Researchers Develop "Three-In-One" Antibodies As A Potential Breakthrough Intervention For HIV/AIDS
Audentes (BOLD) Announces Dosing Of First Patient In ASPIRO, A Phase I/II Clinical Trial Of AT132 For The Treatment Of X-Linked Myotubular Myopathy
Amicus (FOLD) Release: FDA Grants Orphan Drug Designation For ATB200/AT2221 For Pompe Disease
ProQR Therapeutics (PRQR) Presents In Vivo Proof Of Concept Data For The Axiomer RNA Editing Platform Technology
AVROBIO Expands Rare Disease Pipeline With Gene Therapy To Treat Pompe Disease
Inovio Pharma (INO) dMAB Constructs Shrink Prostate Tumors And Protect Against Lethal Antibiotic-Resistant Bacterial Infection In Preclinical Studies
KMR Group Release: 350,000 Reasons Site Scorecard Helps Pharma Select Top Sites
Cannabis Science "Nanoparticle Drones To Target Lung Cancer With Radiosensitizers And Cannabinoids" Full Publication Released Today In Frontiers In Oncology
Veeva Systems, Inc.: Industry Survey Reveals Clinical Data Management Delays Are Slowing Trial Completion
Pfizer (PFE) Release: National Sickle Cell Disease Poll Of African Americans Dispels Long-Held Views
MassBio And Liftstream Study Shows Gender Gap In Life Sciences Sector Perpetuated By Companies’ Culture, Processes And Talent Management
Bristol-Myers Squibb (BMY) Release: New Global Report Finds Majority Of People At High Risk Of Stroke Not Being Screened For Common Risk Factors
Orthopaedic Research Society Release: Microbiome Manipulation Decelerates Osteoarthritis Progression
Millennium Health Release: New Study Finds Heroin-Positive Patients Have Increasing Co-Occurrence Of Non-Prescribed Fentanyl
deCODE genetics (DCGN) Study Reveals An Ancient Achilles Heel In The Human Genome
ProBion Innovation Sweden Announces Colon Cancer Breakthrough: New Probiotic Treatment Markedly Reduces Cancer-Related Microbes
Avara Acquires Consumer Healthcare Facility From GlaxoSmithKline (GSK) In Aiken, South Carolina
Grey Cloak Tech Announces Letter Of Intent To Acquire Eqova Life Sciences
MorphoSys AG Announces That Its Licensee Janssen Biotech (JNJ) Has Initiated Two Phase III Studies With Tremfyatm (Guselkumab) In Psoriatic Arthritis
NicOx SA (COX.PA) Announces Licensing Agreement With Eyevance For Commercialization Of ZERVIATE In The United States
Cellectar Biosciences  (CLRB) Enters Into Strategic Collaboration With Onconova (ONTX) To Develop New Phospholipid Drug Conjugates
Inovalon Announces Agreement With Daiichi Sankyo To Support Outcomes-Based Contracting Partners With Top Pharma To Launch COMPLI, A Global Compliance Standard For Human Biosample Acquisition
Southern Research Release: New Drug Discovery Collaboration Targets Novel Treatments Against Diseases
PhRMA Release: More Than 85 Medicines In Development For Alzheimer's Disease
Merck Canada Release: New First Line Treatment Now Available For Canadians With Metastatic Non-Small Cell Lung Cancer
Lipocine (LPCN) Announces Motions Decision By USPTO In Interference Against Clarus Therapeutics
Orthocell Receives New Patent For Celgro Platform Technology
OncoQR ML's Vaccine Platform Closes The Final Gap In The Immunological Attack Against Cancer
JDRF Funds Zucara Therapeutics' Approach To Preventing Hypoglycemia In People With Type 1 Diabetes
DelMar Pharma Announces $10 Million Registered Direct Offering Priced At-The-Market
Dthera Sciences (DTHR) Approved For Trading On OTCQB Venture Market; Provides Corporate Update
Leading Independent Proxy Advisory Firm Glass Lewis & Co. Recommends CytRx (CYTR) Stockholders Vote "For" The Proposed Reverse Stock Split
Iovance Biotherapeutics Announces Pricing Of Its Public Offering Of $50 Million Of Common Stock
Intellipharmaceutics (IPCI) Announces Receipt Of Nasdaq Notice
Sirona Biochem CEO's Report On Progress
Epigenomics AG Issues New Shares By Way Of Private Placement
Juno (JUNO) Launches Follow-On Offering
CureDuchenne Release: 7th Annual Getzlaf Golf Shootout Raises More Than $546,000 To Help Find A Cure For Duchenne Muscular Dystrophy
Acceleron Pharma Announces Pricing Of Public Offering Of Common Stock
Chronicled And The LinkLab Announce The MediLedger Project, A Revolutionary Blockchain-Backed System To Safeguard The Pharmaceutical Industry
Affinity Bio Partners And Affinity Bioceuticals
Novozymes (NVZMY) Invites Collaboration On Global Challenges
BASF Increases Prices For Ethanolamines In Europe
TRANSGENE (ENX:TNG) Launches Invir.IOTM, Its Integrated Platform For The Next Generation Of Multifunctional Oncolytic Viruses
Contagion Launches First Peer Exchange On Lyme Disease
Danaher (DHR) Schedules Third Quarter 2017 Earnings Conference Call
Mithra Pharmaceuticals Announces 2017 Half Year Results
Poxel (POXEL.PA) Reports Results For The First Half 2017 And Provides Corporate Update
Palatin Tech (PTN) To Report Fourth Quarter And Fiscal Year End 2017 Results; Teleconference And Webcast To Be Held On September 25, 2017
TxCell First-Half 2017 Financial Results And Strategy Update
Alastair McEwan Steps Down As Chief Operating Officer Of Veloxis Pharma (VELO)
CRF Health Augments Global Reach With Official Opening Of Romania Office And Appointment Of New VP Of Global Services
BTS Research Appoints VP Of Toxicology To Oversee Sponsors’ Preclinical Tox Programs
Unity Biotech Appoints Additional Biotech Industry Veterans To Executive Team
Sucampo (SCMP) Appoints Alex Driggs As General Counsel
ERT Named Finalist For 2017 Scrip Award
GILUPI Will Attend At The ACTC Congress In Rhodos
ISPE 2017 Annual Meeting & Expo Keynote Speakers Announced
eTheRNA Immunotherapies To Present At Sachs Biotech In Europe Forum
Pfizer (PFE) Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference
Lisa Estrada, Fresenius Medical Care North America, Joins Movement To Raise $1 Million For Kidney Health
Synlogic To Webcast Presentation At The LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology
La Jolla Pharma (LJPC) Release: Prespecified Analysis Of ATHOS-3 Indicates Survival Benefit In LJPC-501-Treated Patients With Relatively Low Angiotensin II State
Aerie (AERI) Announces FDA Advisory Committee Meeting For Rhopressa (Netarsudil Ophthalmic Solution) 0.02%
Lysogene Holds First Parent Advisory Board In MPS IIIA
Bristol-Myers Squibb (BMY) To Take Part In Leerink Partners Rare Disease & Immuno-Oncology Roundtable Conference
Oregon Bioscience Association Release: Oregon’s Life Science Industry On Display: Oregon Bioscience Showcase 2017
BioTime (BTX) Co-CEO Adi Mohanty To Participate In Panel Discussion At The Cell & Gene Therapy CEO Forum
AgeX Therapeutics, Inc. CEO Michael D. West To Participate In Fireside Chat With J. Craig Venter At The Cell & Gene Therapy CEO Forum
Applied DNA Sciences, Inc. (APDN) To Present At The 2017 Disruptive Growth Company Showcase NYC On September 27
Airbus, Lockheed Martin Get in on Humatics' $18 Million Funding Round
Covalon Technologies Wins FDA Clearance for MediClear PreOp
BrainLAB AG Snags FDA Win for Two New Indication-Specific Radiosurgery Software Applications
FBI Approves DNA Detection Kit to Genetically Identify Male Perpetrators of Sexual Assault
Covalon Technologies Ltd. Announces Major Milestone: FDA Clearance For MediClear PreOp
Breathtec Announces Resignation Of Chief Executive Officer
Bay Area's Relievant Medsystems Names a New CEO
Abiomed (ABMD) Receives FDA PMA Approval For Impella RP For Right Heart Failure
Endologix Announces CE Mark Approval For The Nellix Endovascular Aneurysm Sealing System With The Refined Indications For Use
Paramed Medical Systems: A Study From AECC Bournemouth Demonstrates The Advantages Of Upright MRI
Study Published In Managed Care Regarding Prognostic And Cancer-Care Planning Value Of Biodesix, Inc.’s Veristrat Proteomic Test
Medtronic (MDT) Announces Clinical Study To Evaluate The Corevalve Evolut PRO System In 'Everyday' Clinical Practice
Nemaura Medical Announces Successful Interim Results For Sugarbeat European Clinical Trials
Biogennix Bone Graft Substitute Materials Used To Treat 6000th Patient
Treos Bio Enters Into Agreement With PPD (PPDI) To Manage First-In-Man Trial Of Its Lead Therapeutic Cancer Vaccine Program
The Qt Company Joins AdvaMed And MassMEDIC To Guide Policy And Technology Innovation In The Medical Device Industry
Avita Medical And BARDA Execute A $24.3 Million Contract Option
Qynapse Receives CE Mark For Qyscore Cloud-Based Solution For Automatic Extraction, Quantification And Comparison To Normative Dataset Of Imaging Markers Of CNS Diseases For Use By Pharmaceutical Companies And Healthcare Providers
Genetic Tech (GTG.AX) Transitions To Online Commercial Platform For BREVAGenplus
Medovex Corporation Launches Denervex System In Spain With Distributor PRIM, S.A. (17088411.MA)
ManaMed Introduces PlasmaFlow, The World's First FDA-Approved Digital And Tubeless Deep Vein Thrombosis Prevention Device
Paragon 28 Launches 5th Metatarsal Fracture Specific Plating System, Expanding The Baby Gorilla Mini Plating System Offering
Varian Medical Systems (VAR) Announces Penn Medicine Treats World's First Patient On Halcyon System
SonaCare Medical Reports That CMS Announces Increase To ASC Payment For HIFU Prostate Ablation
Bauer Launches NeuroShield Collar Backed By Research And Development By Q30 Innovations Available In Canada
PolarityTE Announces Closing of $17.75 Million Above Market Private Placement
Profound Medical Corp. Announces Closing Of $10 Million “Bought Deal” Financing
Bionik (BNKL) Announces Capital Raise Through Issuance Of Convertible Notes
MiMedx Responds To Deceptive Short Seller Reports
MiMedx Provides Information On Its Interaction With The SEC
MiMedx Files Lawsuit Against The Capitol Forum
Royal Philips Electronics N.V. (PHG) Release: New Phoenix Children’s Hospital Emergency Department And Level 1 Pediatric Trauma Center Offers Philips Solutions For Connected Patient Experience And Improved Outcomes
BrainLAB AG Announces FDA Clearance For Two New Indication-Specific Radiosurgery Software Applications
Cantel Medical (CMN) To Hold Conference Call To Discuss Results For Its Fourth Quarter And Fiscal Year Ended July 31, 2017
Adhesives Research Appoints Richard Widden, Former Chief Commercial Officer Of Klöckner Pentaplast To President Of Adhesives Research And ARx, LLC.
Boehringer Ingelheim Release: New Documentary Film Shines Light On Physical And Emotional Impact Of COPD
Bio-Rad (BIO) Release: Chromatography Experts To Discuss Novel Downstream Purification Technologies At BioProcess International Conference & Exhibition
SANUWAVE Announces Exhibition At Medica In Cooperation With State Of Georgia; Visit Us At Booth 16D10-8 In Hall 16
Interpace Diagnostics’ CEO Interviewed On The RedChip Money Report